Assessment of Viral Genotype Impact to the Cost-Effectiveness and Overall Costs of Care for Peg-Interferon-2α + Ribavirine Treated Chronic Hepatitis C Patients

BACKGROUND: Pegylated interferon alfa plus ribavirin protocol is currently considered the most efficient hepatitis C treatment. However, no evidence of costs comparison among common viral genotypes has been published. OBJECTIVES: We aimed to assess core drivers of hepatitis C medical care costs and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakovljevic, Mihajlo, Mijailovic, Zeljko, Popovska Jovicic, Biljana, Canovic, Predrag, Gajovic, Olgica, Jovanovic, Mirjana, Petrovic, Dejan, Milovanovic, Olivera, Djordjevic, Natasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3768202/
https://www.ncbi.nlm.nih.gov/pubmed/24032044
http://dx.doi.org/10.5812/hepatmon.6750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3768202/
https://www.ncbi.nlm.nih.gov/pubmed/24032044
http://dx.doi.org/10.5812/hepatmon.6750

Ejemplares similares